EnWave to Report Third Quarter 2019 Financial Results on August 28, 2019
August 21 2019 - 9:00AM
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the
"Company"), a global leader in vacuum microwave
dehydration technology, announced today it will report its
financial results for the third quarter of fiscal year 2019
on Wednesday, August 28, 2019 after market close.
About EnWave EnWave
Corporation, a Vancouver-based advanced technology company, has
developed Radiant Energy Vacuum (“REV™”) – an innovative,
proprietary method for the precise dehydration of organic
materials. EnWave has further developed patent-pending methods for
uniformly drying and decontaminating cannabis through the use of
REV™ technology, shortening the time from harvest to marketable
cannabis products.
REV™ technology’s commercial viability has been
demonstrated and is growing rapidly across several market verticals
in the food, and pharmaceutical sectors including legal cannabis.
EnWave’s strategy is to sign royalty-bearing commercial licenses
with industry leaders in multiple verticals for the use of REV™
technology. The company has signed over twenty royalty-bearing
licenses to date, opening up nine distinct market sectors for
commercialization of new and innovative products. In addition to
these licenses, EnWave has formed a Limited Liability Corporation,
NutraDried Food Company, LLC, to develop, manufacture, market and
sell all-natural cheese snack products in the United States under
the Moon Cheese® brand.
EnWave has introduced REV™ as the new
dehydration standard in the food and biological material sectors:
faster and cheaper than freeze drying, with better end product
quality than air drying or spray drying. EnWave currently has three
commercial REV™ platforms:
- nutraREV® which is used in the food
industry to dry food products quickly and at low-cost, while
maintaining high levels of nutrition, taste, texture and
colour;
- powderREV® which is used for the
bulk dehydration of food cultures, probiotics and fine biochemicals
such as enzymes below the freezing point, and
- quantaREV® which is used for
continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being
developed as a new method to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More
information about EnWave is available at www.enwave.net.
EnWave CorporationBrent
Charleton, CFAPresident and CEO
For further information:
Brent Charleton, CFA, President and CEO at +1
(778) 378-9616 E-mail: bcharleton@enwave.net
Dan Henriques, CPA, CA, Chief Financial Officer
at +1 (604) 835-5212E-mail: dhenriques@enwave.net
Deborah Honig, Corporate Development at +1 (647)
203-8793E-mail: dhonig@enwave.net
Safe Harbour for Forward-Looking Information
Statements: This press release may contain forward-looking
information based on management's expectations, estimates and
projections. All statements that address expectations or
projections about the future, including statements about the
Company's strategy for growth, product development, market
position, expected expenditures, and the expected synergies
following the closing are forward-looking statements. All third
party claims referred to in this release are not guaranteed to be
accurate. All third party references to market information in this
release are not guaranteed to be accurate as the Company did not
conduct the original primary research. These statements are not a
guarantee of future performance and involve a number of risks,
uncertainties and assumptions. Although the Company has attempted
to identify important factors that could cause actual results to
differ materially, there may be other factors that cause results
not to be as anticipated, estimated or intended. There can be no
assurance that such statements will prove to be accurate, as actual
results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
EnWave (TSXV:ENW)
Historical Stock Chart
From Mar 2024 to Apr 2024
EnWave (TSXV:ENW)
Historical Stock Chart
From Apr 2023 to Apr 2024